CHEK1 and vulva cancer: To elucidate the mechanisms by which CHK1 inhibitor affect vulvar cancer cell viability, we analyzed the expression of proteins downstream of CHK1 as well as apoptotic markers after treatment with 500 nM AZD7762 for up to 72 hours.